about
Complement C5-deficient mice are protected from seizures in experimental cerebral malariaCerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?Blood-brain barrier, bulk flow, and interstitial clearance in epilepsyEvidence for Status Epilepticus and Pro-Inflammatory Changes after Intranasal Kainic Acid Administration in MiceDealing with Danger in the CNS: The Response of the Immune System to Injury.WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensityOptimization of pilocarpine-mediated seizure induction in immunodeficient NodScid mice.Hsp60 response in experimental and human temporal lobe epilepsyAlbumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunctionOnly a Touch of the Flu? The Simultaneous Manifestation of Acute Necrotizing Encephalopathy in Two Consanguineous Patients.Initiation, Propagation, and Termination of Partial (Focal) Seizures.Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus.Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Infections, inflammation and epilepsyDecreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti-inflammatory pathway?Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideDefining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.Polymorphisms of toll-like receptors 2 and 9 and severity and prognosis of bacterial meningitis in Chinese children.Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.Purinergic signaling in epilepsy.HMGB1-TLR4 Axis Plays a Regulatory Role in the Pathogenesis of Mesial Temporal Lobe Epilepsy in Immature Rat Model and Children via the p38MAPK Signaling Pathway.Pediatric Autoimmune Epileptic Encephalopathies.Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle.Kainic acid-induced albumin leak across the blood-brain barrier facilitates epileptiform hyperexcitability in limbic regions.Cyclooxygenase-1 as a Potential Therapeutic Target for Seizure Suppression: Evidences from Zebrafish Pentylenetetrazole-Seizure Model.Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A.The role of substance P in epilepsy and seizure disorders.α-Asarone Attenuates Cognitive Deficit in a Pilocarpine-Induced Status Epilepticus Rat Model via a Decrease in the Nuclear Factor-κB Activation and Reduction in Microglia Neuroinflammation.Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons.Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury.Cerebrospinal fluid neuron specific enolase, interleukin-1β and erythropoietin concentrations in children after seizures.Effects of dexamethasone on the Li-pilocarpine model of epilepsy: protection against hippocampal inflammation and astrogliosis.
P2860
Q27312562-5A30316A-76C9-4908-9537-150B17BF8075Q27693854-925A0ED1-3313-4650-9FE7-1EC6FCD6B11AQ28086846-CAD12A81-2C0E-4B35-BB78-342CE4FDB73AQ28550698-0DD986C8-89B4-43C4-9443-6BCA4046BB9BQ30279070-B94124BE-D0B1-4FF9-BA66-41FADE73E189Q33915194-5A6B5E0A-5B70-4756-B98A-7F403F1A45CCQ34125778-95BF389B-69BF-4C4A-BD3E-8A3AF6C83A64Q34755918-CA99D8AB-096E-40FD-AE48-405F82887BDBQ35210709-68A5908C-DD03-4A28-B667-9C137277E978Q35588910-8F5468DE-571C-4B86-A188-7E6D209A0D04Q35757365-3D60FBBC-06E2-4B9A-91B8-46D612A7E9DFQ35795541-3D68D45F-D597-4EF0-9572-2589C7B7D069Q36155325-315E497F-A746-4258-BF4C-C22A3037CA37Q36343295-0720D5FF-A77C-4B74-9637-F7109E819D5CQ36815367-1E237626-F7DB-457C-BDC1-8DE393AA815EQ36902812-8130CC71-7584-42F8-8227-A402CD2856AEQ36972470-73EE08D3-A30F-467C-9ABB-547C852354EBQ37340703-7B89D19A-C134-42C7-B132-6D0233C9206DQ37350938-71D79A90-24A0-4230-99B3-95209B8600DCQ37644234-C70C560A-98B1-417F-9F9A-A496ED7E8982Q38341967-57592B39-AE9E-4CBA-9C3A-2D4E08F58320Q38707729-8914DA6C-EFBB-42C6-B89B-42F46F89ECABQ38865526-534A345D-98F3-40C3-AC55-A955EB40288DQ38973018-06594C8B-430B-48E5-B109-0D10FB2539C5Q39068563-8892FCCD-1605-418F-8896-E78831C8C773Q39291870-0EC1363F-7E9D-4F65-9F3E-FDBAAF78554BQ39771233-FF2BF84A-BB94-4C34-85D6-16BF77510193Q41884924-74F59E94-A475-4533-BABF-B302FDA7DE92Q42030450-EFB9EDBD-C70D-41C5-BC92-7BD3E5096786Q44221614-EF366F34-5C6D-4A87-AD45-93127D1F168AQ47194378-60EA1133-877A-4E6A-AE87-F48286EA2457Q47417355-23E0BC3B-13AC-43D3-AD86-17BA698BEC6AQ47869408-88B74916-FAFD-4612-8433-4E7790872D53Q47893052-42AF7454-EFFD-473C-B3C4-6DFBDB79160AQ48112617-BBE11F4F-EA5F-43E0-93DD-B33AB4D0AE20Q52611789-FAA12373-CC08-4E97-8A06-BDABCB38E0E9Q53479803-73C75308-15AA-4F9E-874D-1009A2C9BC83Q55426524-72B3523B-8644-4D31-9730-3C8AFB487F50
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammatory pathways of seizure disorders.
@en
type
label
Inflammatory pathways of seizure disorders.
@en
prefLabel
Inflammatory pathways of seizure disorders.
@en
P2860
P50
P1476
Inflammatory pathways of seizure disorders.
@en
P2093
Tiziana Granata
P2860
P356
10.1016/J.TINS.2013.11.002
P577
2013-12-16T00:00:00Z